HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice

MLA

Daisuke Ibi, et al. “HDAC2-Dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice.” Neuroscience, vol. 388, Sept. 2018, pp. 102–17. EBSCOhost, https://doi.org/10.1016/j.neuroscience.2018.07.010.

APA

Daisuke Ibi, Terrell Holloway, Maryum K. Ijaz, Rudy Toneatti, Jeremy Seto, Mikhail G. Dozmorov, Li Shen, Travis Cuddy, Javier González-Maeso, Mario de la Fuente Revenga, Mitsumasa Kurita, & Justin M. Saunders. (2018). HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice. Neuroscience, 388, 102–117. https://doi.org/10.1016/j.neuroscience.2018.07.010

Chicago

Daisuke Ibi, Terrell Holloway, Maryum K. Ijaz, Rudy Toneatti, Jeremy Seto, Mikhail G. Dozmorov, Li Shen, et al. 2018. “HDAC2-Dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice.” Neuroscience 388 (September): 102–17. doi:10.1016/j.neuroscience.2018.07.010.